"59538" . "[A5F358E40BEC]" . . . "Adherence a mo\u017Enosti jej\u00EDho ovlivn\u011Bn\u00ED" . "Adherence and how to influence it"@en . "Adherenci k l\u00E9\u010Db\u011B se v\u011Bnuje v posledn\u00EDch letech nemal\u00E1 pozornost. Ji\u017E v\u00EDme, \u017Ee spolupr\u00E1ce s nemocn\u00FDmi v\u00FDznamn\u011B ovliv\u0148uje v\u00FDsledek l\u00E9\u010Dby a mysl\u00EDme na non-adherentn\u00ED chov\u00E1n\u00ED \u010Dast\u011Bji. Existuje \u0159ada zp\u016Fsob\u016F, jak adherenci ovlivnit. Hlavn\u00ED roli hraje v tomto sm\u011Bru l\u00E9ka\u0159 a dal\u0161\u00ED zdravotn\u00EDci. Opakovan\u00E1, systematick\u00E1 edukace s vyu\u017Eit\u00EDm prost\u0159edk\u016F zlep\u0161uj\u00EDc\u00ED jej\u00ED \u00FA\u010Dinnost (p\u00EDsemn\u00E1 dokumentace, vyu\u017Eit\u00ED n\u00E1zorn\u00FDch materi\u00E1l\u016F, model\u016F) zlep\u0161uj\u00ED pochopen\u00ED onemocn\u011Bn\u00ED i l\u00E9\u010Debn\u00E9 intervence ze strany pacienta, co\u017E je nezbytn\u00FDm p\u0159edpokladem pro zlep\u0161en\u00ED spolupr\u00E1ce. Nepochybn\u011B d\u016Fle\u017Eit\u00FDm prvkem strategie ke zlep\u0161en\u00ED adherence je volba racion\u00E1ln\u00ED farmakologick\u00E9 l\u00E9\u010Dby s d\u016Frazem nejen na \u00FA\u010Dinnost, ale i dobrou toleranci. \u010Cas v\u011Bnovan\u00FD t\u00E9to problematice se jist\u011B vr\u00E1t\u00ED v podob\u011B lep\u0161\u00EDch v\u00FDsledk\u016F l\u00E9\u010Dby a v kone\u010Dn\u00E9m d\u016Fsledku i ve zlep\u0161en\u00ED progn\u00F3zy nemocn\u00FDch."@cs . "Adherence to treatment has been paid a great deal of attention in recent years. We already know that cooperation with patients significantly affects treatment outcome and non-adherent behaviour borne in mind more often. There are a number of ways how to influence adherence. The main role in this regard is played by the physician and other health care workers. Repeated, systematic education with the use of methods improving its efficacy (written documentation, use of illustrative materials and models) increases the understanding of the disease as well as the therapeutic intervention by the patient, which is an essential precondition for improved cooperation. The choice of rational pharmacological treatment with an emphasis not only on efficacy but also good tolerance is undoubtedly an important element in the strategy towards improved adherence. The amount of time devoted to this issue will certainly pay off in the form of better treatment outcomes and, ultimately, in improved prognosis of the patients."@en . . . . "I" . . "11-12" . "Adherenci k l\u00E9\u010Db\u011B se v\u011Bnuje v posledn\u00EDch letech nemal\u00E1 pozornost. Ji\u017E v\u00EDme, \u017Ee spolupr\u00E1ce s nemocn\u00FDmi v\u00FDznamn\u011B ovliv\u0148uje v\u00FDsledek l\u00E9\u010Dby a mysl\u00EDme na non-adherentn\u00ED chov\u00E1n\u00ED \u010Dast\u011Bji. Existuje \u0159ada zp\u016Fsob\u016F, jak adherenci ovlivnit. Hlavn\u00ED roli hraje v tomto sm\u011Bru l\u00E9ka\u0159 a dal\u0161\u00ED zdravotn\u00EDci. Opakovan\u00E1, systematick\u00E1 edukace s vyu\u017Eit\u00EDm prost\u0159edk\u016F zlep\u0161uj\u00EDc\u00ED jej\u00ED \u00FA\u010Dinnost (p\u00EDsemn\u00E1 dokumentace, vyu\u017Eit\u00ED n\u00E1zorn\u00FDch materi\u00E1l\u016F, model\u016F) zlep\u0161uj\u00ED pochopen\u00ED onemocn\u011Bn\u00ED i l\u00E9\u010Debn\u00E9 intervence ze strany pacienta, co\u017E je nezbytn\u00FDm p\u0159edpokladem pro zlep\u0161en\u00ED spolupr\u00E1ce. Nepochybn\u011B d\u016Fle\u017Eit\u00FDm prvkem strategie ke zlep\u0161en\u00ED adherence je volba racion\u00E1ln\u00ED farmakologick\u00E9 l\u00E9\u010Dby s d\u016Frazem nejen na \u00FA\u010Dinnost, ale i dobrou toleranci. \u010Cas v\u011Bnovan\u00FD t\u00E9to problematice se jist\u011B vr\u00E1t\u00ED v podob\u011B lep\u0161\u00EDch v\u00FDsledk\u016F l\u00E9\u010Dby a v kone\u010Dn\u00E9m d\u016Fsledku i ve zlep\u0161en\u00ED progn\u00F3zy nemocn\u00FDch." . "1"^^ . "RIV/00064165:_____/13:10190825!RIV14-MZ0-00064165" . "http://www.medicinapropraxi.cz/pdfs/med/2013/11/03.pdf" . "1214-8687" . . "Vrabl\u00EDk, Michal" . "1"^^ . . "Medic\u00EDna pro praxi" . . "education; dyslipidemia; hypertension; cardiovascular risk; Adherence"@en . . . . "Adherence and how to influence it"@en . . "CZ - \u010Cesk\u00E1 republika" . . . . . "RIV/00064165:_____/13:10190825" . "Adherence a mo\u017Enosti jej\u00EDho ovlivn\u011Bn\u00ED"@cs . "3"^^ . "10" . "Adherence a mo\u017Enosti jej\u00EDho ovlivn\u011Bn\u00ED" . "Adherence a mo\u017Enosti jej\u00EDho ovlivn\u011Bn\u00ED"@cs .